Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): Cause or consequence?
Keywords: autoimmunity; MDS; AML; CMML; Treg
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Assessing and taking into account the subjects’ experience and knowledge in consumer studies. Application to the free sorting of wine glasses
Keywords: Perception; Consumer; Free sorting; Rasch model; MDS; Central partition
Molecular genetics in myelodysplastic syndromes
Keywords: Myelodysplastic syndromes; MDS; WHO-classification; Cytogenetics; Molecular markers;
Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML
Keywords: Duplication 1q; MDS; AML; t(8;21); Survivorship
Application of allele-specific quantitative PCR using genomic DNA to monitor minimal residual disease based on mutant gene levels following allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: Comparison of mutan
Keywords: MRD; minimal residual disease; HSCT; hematopoietic stem cell transplantation; AS-qPCR; allele-specific quantitative polymerase chain reaction; STR-PCR; short tandem repeat-PCR; AML; acute myelogenous leukemia; MDS; myelodysplastic syndrome; BM; bone marro
The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure
Keywords: MDS; FISH; Cytogenetics; Normal karyotype; Complex karyotype
Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS
Keywords: MDS; Diagnostic criteria; Pre-malignant lesions; ICUS; IDUS
When are apparently non-clonal abnormalities in bone marrow chromosome studies actually clonal?
Keywords: Myelodysplasia; myelodysplastic syndrome; MDS; cytogenetics
The Association Between Pain and Measures of Well-Being Among Nursing Home Residents
Keywords: Pain; MDS; nursing home; activities of daily living; elderly;
Clustering of UPOINT Domains and Subdomains in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Contribution to Symptom Severity
Keywords: prostate; prostatitis; chronic pain; phenotype; cluster analysis; CP/CPPS; chronic prostatitis/CPPS; CPPS; chronic pelvic pain syndrome; MDS; multidimensional scaling; PBS/IC; painful bladder syndrome/interstitial cystitis; QOL; quality of life;
Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na
Keywords: MDS; Treatment; ON 01910.Na; Rigosertib; Nanoimmunoassay; AKT signaling pathway
Genetic diversity and admixture patterns in Indian populations
Keywords: MDS; Multidimensional scaling; PCA; Principal component analysis; Fst; Fixation index; Fis; Inbreeding coefficient; ANI; Ancestral North Indian; ASI; Ancestral South Indian; StyI; StyI restriction endonuclease; NspI; NspI restriction endonuclease; TE; Tri
Functional outcome of a novel SLC29A3 mutation identified in a patient with H syndrome
Keywords: MDS; mtDNA depletion syndrome; Nucleoside transporter; mtDNA depletion; SLC29A3; mtDNA copy number; H syndrome;
A novel homozygous mutation in SUCLA2 gene identified by exome sequencing
Keywords: MDS; mtDNA depletion syndrome; MMA; methylmalonic acid; MRC; mitochondrial respiratory chain; mtDNA; mitochondrial DNA; NGS; next-generation sequencing; OXPHOS; oxidative phosphorylation; Mitochondrial disorder; Encephalomyopathy; Mitochondrial DNA deplet
SDF-1/CXCR4 axis in myelodysplastic syndromes: Correlation with angiogenesis and apoptosis
Keywords: SDF-1/CXCR4; Angiogenesis; Apoptosis; MDS;
Quantity of clonal cells detected by conventional cytogenetic analysis correlates with bone marrow blasts and survival in myelodysplastic syndromes
Keywords: Quantity; Clonality; Conventional cytogenetic analysis; FISH; MDS;
Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells
Keywords: MDS; Methylation; Wnt pathway; Wnt antagonists; β-Catenin; Azacitidine;
Imprinted gene expression in fetal growth and development
Keywords: Genomic imprinting; Placenta; Imprinted gene expression; Fetal development; AGA; Appropriate for Gestational Age; ICR; Imprinting Control Region; IPA; Ingenuity Pathway Analysis; IUGR; Intrauterine Growth Restriction; LGA; Large for Gestational Age; MDS;
Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis
Keywords: Iron chelation therapy; Myelodysplastic syndrome; MDS; RARS; Survival; Lower IPSS risk;
Extended Spectrum of Human Glucose-6-Phosphatase Catalytic Subunit 3 Deficiency: Novel Genotypes and Phenotypic Variability in Severe Congenital Neutropenia
Keywords: AML; Acute myeloid leukemia; CN; Congenital neutropenia; ELANE; Neutrophil elastase; G6PC3; Glucose-6-phosphatase catalytic subunit 3; HAX1; HS1-associated protein X1; HSCT; Hematopoietic stem cell transplantation; MDS; Myelodysplastic syndrome; SCN; Seve
Overexpression of MCM2 in myelodysplastic syndromes: Association with bone marrow cell apoptosis and peripheral cytopenia
Keywords: MCM2; MDS; Apoptosis; Cellular proliferation; Immunohistochemistry; Bone marrow
Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na
Keywords: MDS; Treatment; ON 01910.Na; Cyclin D1;
Computational investigation of pathogenic nsSNPs in CEP63 protein
Keywords: CEP63; Centrosomal protein of 63Â kDa; nsSNPs; Non-synonymous single nucleotide polymorphisms; CDK1; Cyclin-dependent kinase 1; MDS; Molecular dynamics simulation; RMSD; Root-mean-square deviation; Rg; Radius of gyration; SASA; Solvent-accessible surface
Surface charge and wetting characteristics of layered silicate minerals
Keywords: Layered silicates; Surface charge; Wettability; AFM; MDS;
Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome
Keywords: MDS; Circulating DNA; Genetic mutations; Epigenetics; LINE-1; TET2;
Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS
Keywords: MDS; Diagnosis; Flow cytometry; Implementation; Standardization; Multicenter analysis; Pitfalls
Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
Keywords: Myelodysplastic syndrome; MDS; Chromosome analysis; FISH; Fluorescence in situ hybridization; Bone marrow; Peripheral blood;
An interactive cluster-based MDS localization scheme for multimedia information in wireless sensor networks
Keywords: Clustering; MDS; Localization; Range-free; WSN
In silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ)
Keywords: STIL protein; Docking; Molecular dynamics simulation; CENPJ protein; STIL; SCL/TAL1 interrupting locus; CENPJ; Centromere protein J; MDS; Molecular dynamics simulation; RMSD; Root-mean-square deviation; Rg; Radius of gyration; SASA; Solvent-accessible sur
Comorbidity and geriatric assessment for older patients with hematologic malignancies: A review of the evidence
Keywords: Comorbidity; CGA; Predictive scores; Charlson; CIRS-G; Hematopoietic cell; ADL; IADL; Geriatric syndromes; Frailty; Leukemia; Lymphoma; MDS; Myeloma; CLL
In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion
Keywords: COX; cytochrome c oxidase; COX II; cytochrome c oxidase subunit II; DGUOK; deoxyguanosine kinase; dNMP; deoxy-nucleoside monophosphate; dNDP; deoxy-nucleoside diphosphate; dNTP; deoxy-nucleoside triphosphate; HIV; human immunodeficiency virus; HRP; horser
Computational screening and molecular dynamics simulation of disease associated nsSNPs in CENP-E
Keywords: CENP-E; centromere-associated protein-E; nsSNPs; non-synonymous single nucleotide polymorphisms; MDS; molecular dynamics simulation; RMSD; root-mean-square deviation; Rg; radius of gyration; SASA; solvent-accessible surface area; RMSF; root-mean square fl
Azacitidine differentially affects CD4pos T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes
Keywords: Azacitidine; Cytokines; Regulatory T-cells; IL-17; CD4 T-helper cells; MDS;
Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome
Keywords: MDS; conventional cytogenetics; FISH; TET2
The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes
Keywords: MDS; Transfusions; Iron overload; Quality of life;
Combining microdilution with MicroRespâ¢: Microbial substrate utilization, antimicrobial susceptibility and respiration
Keywords: CFU; colony forming units; G; growth; GE; growth efficiency; MS; Murashige-Skoog; GC-MS; gas chromatography-mass spectroscopy; LB; Luria-Bertani; MDS; multidimensional scaling; MEA; malt extract agar; R; respiration; TSA; tryptic soy agar; Antimicro
Application of vitamin D and derivatives in hematological malignancies
Keywords: MDS; myelodysplastic syndrome (preleukemia); AML; acute myelogenous leukemia; CML; chronic myelogenous leukemia; CMML; chronic myelomonocytic leukemia; NHL; non-Hodgkin's lymphoma; Vitamin D; Hematological malignancies; Intracellular kinases; Multiple m
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Keywords: Hypereosinophilic syndrome; eosinophilic leukemia; criteria; classification; hypereosinophilia of undetermined significance; BM; Bone marrow; CEL; Chronic eosinophilic leukemia; FGFR; Fibroblast growth factor receptor; HE; Hypereosinophilia; HEN; Primary
Chromatin-modifying agents in anti-cancer therapy
Keywords: Epigenetic inhibitors; HDAC; DNMT; Anti-cancer therapy; Clinical trials; Combinatory treatments; AML; acute myeloid leukemia; AZA; 5-azacytidine; CMA; chromatin-modifying agent; CML; chronic myeloid leukemia; CMML; chronic myelomonocytic leukemia; CTCL; c
A raison d'être for two distinct pathways in the early steps of plant isoprenoid biosynthesis?
Keywords: AACT; acetoacetyl-coenzyme A thiolase; Ac-CoA; acetyl-coenzyme A; AcAc-CoA; acetoacetyl-coenzyme A; ADP; adenosine diphosphate; ATP; adenosine triphosphate; CDP-ME; 4-diphosphocytidyl-2C-methyl-d-erythritol; CDP-MEP; 4-diphosphocytidyl-2C-methyl-d-erythri
Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome
Keywords: Myelodysplastic syndrome; MDS; Arsenic; Low-dose cytarabine;
Platelet Recovery Before Allogeneic Stem Cell Transplantation Predicts Posttransplantation Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Keywords: CRp; Platelet recovery; AML; MDS; Transplant
Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission
Keywords: AML; MDS; Leukemia; Allogeneic transplant
hCLP46 regulates U937 cell proliferation via Notch signaling pathway
Keywords: hCLP46; human CAP10-like protein 46Â kDa; Poglut; protein O-glucosyltransferase; Poglut1; protein O-glucosyltransferase1 (mammalian); CDKI; cyclin-dependent kinase inhibitor; CDKN1B (p27); cyclin-dependent kinase inhibitor 1B; RB; retinoblastoma; CSL; CBF
On visual complexity of 3D shapes
Keywords: 3D shape complexity; Shape perception; View similarity; MDS
Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia
Keywords: -7; del(7q); tyrosine kinase inhibitor; MDS; AML; CML; Philadelphia negative
Validation of the Minimum Data Set in Identifying Hospitalization Events and Payment Source
Keywords: MDS; nursing home; data quality; hospitalization; payment source;
Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life
Keywords: AML; mds; Preparative regimen; Busulfan; Elderly
Molecular dynamics simulations of metal–cyanide complexes: Fundamental considerations in gold hydrometallurgy
Keywords: Metal–cyanide complex; MDS; Hydration state